Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Haven Protocol XHV Mar 6, 2021 8.24 +6.22   
 HazeCoin HAZE Mar 6, 2021 0.01 0.00   
 Hdac HDAC Mar 6, 2021 0.02 +55.39   
 HeartBout HB Mar 6, 2021 0.00 +3.65   
 Hedera Hashgraph HBAR Mar 6, 2021 0.14 -3.20   
 Hedgecoin HEDG Mar 6, 2021 1.11 -1.17   
 HEROcoin PLAY Mar 6, 2021 0.01 -2.88   
 HEX HEX Mar 6, 2021 0.01 -1.81   
 High Performance Blockchain HPB Mar 6, 2021 0.15 +10.69   
 Hive HVN Mar 6, 2021 0.00 +15.21   
 Hive HIVE Mar 6, 2021 0.29 +3.77   
 Homeros HMR Mar 6, 2021 0.05 -3.01   
 HOQU HQX Mar 6, 2021 0.00 +42.31   
 Humaniq HMQ Mar 6, 2021 0.01 +3.62   
 Huobi Pool Token HPT Mar 6, 2021 0.02 +0.88   
 Huobi Token HT Mar 6, 2021 15.12 +1.82   
 Hxro HXRO Mar 6, 2021 0.31 +0.86   
 HYCON HYC Mar 6, 2021 0.00 -18.75   
 Hydro Protocol HOT Mar 6, 2021 0.01 -3.80   
 HyperCash HC Mar 6, 2021 0.90 +3.92   
 HyperDAO HDAO Mar 6, 2021 0.01 +3.83   
 Hyperion HYN Mar 6, 2021 0.02 -11.92   
 I-House Token IHT Mar 6, 2021 0.00 +6.35   
 ICON Project ICX Mar 6, 2021 1.79 +0.73   
 IDEX IDEX Mar 6, 2021 0.07 +12.49   
 iEx.ec RLC Mar 6, 2021 1.60 +4.30   
 Ignis IGNIS Mar 6, 2021 0.09 +20.96   
 IndaHash IDH Mar 6, 2021 0.01 +5.09   
 Infinito INFT Mar 6, 2021 0.00 +44.24   
 Infinity Economics XIN Mar 6, 2021 0.00 +3.65   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Data:


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK